The Pharma Review
Overview
The Pharma Review is an English-language, bi-monthly journal for the pharmaceutical industry, published by Kongposh Publications Pvt. Ltd. from New Delhi. It is an article-based journal — built around contributed articles rather than news reporting — and it describes its field as the whole pharmaceutical industry, earning it the description used in its catalogue listings of an umbrella journal of the pharma industry. The Pharma Review is a registered trademark of its publisher, and the title has been part of Indian pharmaceutical publishing since the early 2000s.
The journal is read, according to its media listings, by decision makers, middle management and academia within the pharmaceutical sector. That readership defines its character: this is a professional journal for people who run, manage, research and teach pharmacy and pharmaceutical business, published six times a year from the Indian capital.
Publisher and History
The Pharma Review is published by Kongposh Publications, a New Delhi publishing house devoted to the pharmaceutical field. The publisher's own listings date its establishment to 2001, and describe it as one of the leading pharma publishers of India. Alongside The Pharma Review, Kongposh publishes the Indian Pharma Reference Guide, an annual reference work, and a list of specialised books in the field, including volumes on regulations on clinical trials, a compendium of transfusion medicine, a book on elements of pharmacovigilance, and a work on content uniformity of pharmaceutical formulations by Dr. P. D. Sethi, as well as reference material on AYUSH and Indian systems of medicine in digital form.
That list reveals the publisher's shape: Kongposh is not a general publisher with a pharma title, but a specialist house whose entire programme — journal, annual reference guide and technical books — serves the pharmaceutical profession. The Pharma Review is its flagship periodical, the recurring publication around which the house's relationships with the industry's authors, advertisers and event organisers are organised.
An Article-Based Journal
The Pharma Review defines itself as an article-based journal, and its content comes substantially from contributions. Its listings note that contributions received from eminent pharma personalities from India as well as other countries give it varied and rich content. The publisher's description of the journal's programme lists the material readers can expect: the latest industry updates and news, review articles, research and development papers, management and marketing articles, and addresses and contacts facilitating business-to-business exchange, together with information on pharma exhibitions and conferences from around the world.
That mixture is characteristic of the Indian pharmaceutical trade journal at its most useful. Review articles and R&D papers serve the journal's academic and research readers; management and marketing articles serve the industry's commercial leadership; industry updates keep both groups current; and the contact and exhibition information turns the journal into a working tool for business development. A single bi-monthly issue is meant to be read by a formulation scientist, a marketing manager and a professor of pharmacy with each finding material addressed to them — the umbrella idea in practice.
Indexing and Scholarly Standing
The Pharma Review is abstracted and indexed by International Pharmaceutical Abstracts in the United States and by Chemical Abstracts in the United States, according to its catalogue listings. Indexing in those two services matters for an article-based journal: International Pharmaceutical Abstracts is the principal abstracting service for pharmaceutical literature, and Chemical Abstracts serves the chemical sciences on which pharmacy depends. Being covered by them places the journal's articles within the searchable record of pharmaceutical literature, so that a review or paper published in New Delhi can be found by researchers working from abstract databases elsewhere.
For contributors, that indexing is part of the journal's offer: the publisher presents The Pharma Review as an excellent platform for authors, researchers and advertisers alike. Academics whose work requires publication in indexed outlets, industry specialists writing review articles, and researchers presenting R&D work all have reason to publish where their articles will be abstracted and discoverable, and the journal's indexing supports its claim to be a serious professional forum rather than a purely commercial trade paper.
Frequency and Formats
The Pharma Review is a bi-monthly journal, appearing six times a year. The publisher distributes it in both soft and hard copies — print issues for subscribers and readers, and digital copies extending its reach. Distribution is reinforced by the journal's presence at industry events: the publisher is a media partner to dozens of expos and conferences around the world, at which copies of The Pharma Review, in print and digital form, are distributed. Listings for the journal variously describe participation and distribution at over twenty expos and conferences worldwide each year, and media partnership arrangements with over forty events.
This event-led distribution is an important part of the journal's model. Pharmaceutical professionals gather at exhibitions and conferences; a journal that is physically and digitally present at those gatherings reaches its exact readership at the moment they are thinking about their industry, and its advertisers reach them with it. Between events, subscription copies carry the journal into company offices, research establishments and academic institutions across India and beyond.
Audience: Industry and Academia Together
The journal's stated audience spans the pharmaceutical world's two halves. On the industry side, it is widely read by decision makers and middle management — the executives, plant and quality heads, and marketing leadership of pharmaceutical companies. On the academic side, it is read by the academia: the pharmacy institutes and university departments that train the industry's future professionals and produce much of its research. Its contributors, drawn from eminent pharma personalities in India and other countries, come from both halves as well.
Serving both audiences is a deliberate positioning. The pharmaceutical industry depends on a continuous exchange between research and manufacture, between the laboratory and the market; a journal read on both sides of that exchange can host it. Management and marketing articles sit in the same journal as review articles and R&D papers because its readers' professional lives cross the same boundary. The Pharma Review's self-description as an umbrella journal is a claim about exactly this breadth of readership under one title.
Language and Reach
The Pharma Review is published in English, the working language of India's pharmaceutical industry and of its regulatory and scientific establishment. English is what allows the journal to operate nationally — India has no single other language shared by the pharma professionals of Mumbai, Hyderabad, Ahmedabad, Bengaluru and New Delhi — and internationally, drawing contributions from pharma personalities in other countries and distribution at conferences around the world.
Its base is New Delhi, which places the journal close to the national regulatory and policy establishment its readers deal with, and its scope is recorded in media directories as national. Between its subscription distribution, its conference presence on multiple continents, and its indexing in American abstracting services, the journal's reach is considerably wider than a purely domestic trade paper, while its subject remains the pharmaceutical industry as seen from India.
The Publisher's Wider Programme
The Pharma Review does not stand alone in its publisher's list, and its companion publications clarify its role. The Indian Pharma Reference Guide, published annually by Kongposh, is the house's reference annual; the journal is its periodical voice. The house's books — on clinical trial regulations, transfusion medicine, pharmacovigilance and pharmaceutical formulation — are the long-form, shelf-life publications against which the bi-monthly journal supplies currency: updates, news and new articles six times a year.
Kongposh also describes its endeavour in business-to-business terms: facilitating B2B forums for the development of business and exchange of ideas, and ensuring maximum mileage for its advertisers. The journal is the centrepiece of that activity, the publication through which the publisher's network of authors, advertisers, event partners and readers is maintained between annuals and book projects.
Role in Indian Pharmaceutical Publishing
India's pharmaceutical industry is one of the largest in the world by volume, and it supports a dense ecosystem of professional media. Within that ecosystem, The Pharma Review occupies the article-journal niche: not a newspaper of daily industry news, nor a purely academic research journal, but a bi-monthly forum in which the industry's specialists write at article length about research, regulation, management and markets, for an audience of their peers in industry and academia. Its indexing in International Pharmaceutical Abstracts and Chemical Abstracts, its international contributor base, and its systematic presence at the industry's exhibitions and conferences have sustained that position across more than two decades of bi-monthly publication.
For the directory reader, the essentials are these: an English-language, bi-monthly, article-based pharmaceutical journal; published by the specialist house Kongposh Publications from New Delhi; indexed in the United States by International Pharmaceutical Abstracts and Chemical Abstracts; read by decision makers, middle management and academics; and distributed in print and digital form, including at pharma expos and conferences worldwide.
How to Read and Subscribe
The Pharma Review is available by subscription from Kongposh Publications in New Delhi, in print, with digital copies also distributed, including through the publisher's media partnerships at pharmaceutical exhibitions and conferences in India and abroad. The publisher's website, kppub.com, is the journal's official home and the route for subscription, contribution and advertising enquiries. The journal is also catalogued in digital magazine libraries as an English, bi-monthly publication from India, through which institutional readers can access it.
